| 51 |
32867720 | Urine concentration ability is reduced to the same degree in adult dominant polycystic kidney disease compared with other chronic kidney diseases in the same CKD-stage and lower THAN in healthy control subjects - a CASE control study. | 2020 Aug 31 |
1 |
| 52 |
33029488 | Identification of Candidate Genes Associated with Charcot-Marie-Tooth Disease by Network and Pathway Analysis. | 2020 |
1 |
| 53 |
33123363 | Regulation of urinary calcium excretion by vasopressin. | 2020 Oct |
4 |
| 54 |
33155896 | Pituitary Dysfunction as a Cause of Cardiovascular Disease. | 2020 |
1 |
| 55 |
33222764 | Primary polydipsia: Update. | 2020 Sep |
1 |
| 56 |
33774620 | A Journey through the Early Evidence Linking Hydration to Metabolic Health. | 2020 |
1 |
| 57 |
29057582 | An exploratory pilot study with copeptin as a biomarker for individualizing treatment for nocturnal polyuria. | 2019 Jan |
1 |
| 58 |
29595346 | A proteomic approach reveals the variation in human platelet protein composition after storage at different temperatures. | 2019 |
1 |
| 59 |
30460574 | Relationship between non-osmotic arginine vasopressin secretion and hemoglobin A1c levels in adult patients with congenital heart disease. | 2019 May |
1 |
| 60 |
30566641 | Water Supplementation Reduces Copeptin and Plasma Glucose in Adults With High Copeptin: The H2O Metabolism Pilot Study. | 2019 Jun 1 |
8 |
| 61 |
30800291 | Vasopressin-aquaporin-2 pathway: recent advances in understanding water balance disorders. | 2019 |
3 |
| 62 |
30945068 | Long non-coding RNA and mRNA analysis of Ang II-induced neuronal dysfunction. | 2019 Jun |
1 |
| 63 |
31004513 | Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis. | 2019 Jul |
1 |
| 64 |
31189221 | New insights into the transcriptional regulation of aquaporin-2 and the treatment of X-linked hereditary nephrogenic diabetes insipidus. | 2019 Jun 30 |
3 |
| 65 |
31274842 | Vascular Protection and Decongestion Without Renin-Angiotensin-Aldosterone System Stimulation Mediated by a Novel Dual-Acting Vasopressin V1a/V2 Receptor Antagonist. | 2019 Jul |
1 |
| 66 |
31280960 | An effective "water injection"-assisted method for excision of ovarian endometrioma by laparoscopy. | 2019 Sep |
1 |
| 67 |
31284689 | Of Mice and Men-The Physiology, Psychology, and Pathology of Overhydration. | 2019 Jul 7 |
1 |
| 68 |
31300862 | Small molecules for modulating the localisation of the water channel aquaporin-2-disease relevance and perspectives for targeting local cAMP signalling. | 2019 Sep |
3 |
| 69 |
31333616 | Feasability of Introducing a Thioether Ring in Vasopressin by nisBTC Co-expression in Lactococcus lactis. | 2019 |
1 |
| 70 |
31369749 | Pathophysiological Mechanisms of Nocturia and Nocturnal Polyuria: The Contribution of Cellular Function, the Urinary Bladder Urothelium, and Circadian Rhythm. | 2019 Nov |
2 |
| 71 |
31400337 | Safety and Efficacy of Vasopressin After Fontan Completion: A Randomized Pilot Study. | 2019 Dec |
1 |
| 72 |
31516170 | EXERCISE-ASSOCIATED HYPONATREMIA. | 2019 |
1 |
| 73 |
31588538 | Nephrogenic Diabetes Insipidus. | 2019 |
2 |
| 74 |
32097916 | Hypervolemic Hyponatremia (Liver). | 2019 |
1 |
| 75 |
32097945 | Physiology and Pathophysiology of Water Homeostasis. | 2019 |
1 |
| 76 |
28967192 | Polyuria-polydipsia syndrome: a diagnostic challenge. | 2018 Mar |
3 |
| 77 |
29182412 | The Effect of Water Loading on Acute Weight Loss Following Fluid Restriction in Combat Sports Athletes. | 2018 Nov 1 |
2 |
| 78 |
29241593 | Rapid differential diagnosis of diabetes insipidus in a 7-month-old infant: The copeptin approach. | 2018 Jan |
1 |
| 79 |
29422070 | Copeptin levels and commonly used laboratory parameters in hospitalised patients with severe hypernatraemia - the "Co-MED study". | 2018 Feb 9 |
2 |
| 80 |
29472379 | DIAGNOSIS OF ENDOCRINE DISEASE: The role of the desmopressin test in the diagnosis and follow-up of Cushing's syndrome. | 2018 May |
2 |
| 81 |
29472987 | Adult female with symptomatic AVPR2-related nephrogenic syndrome of inappropriate antidiuresis (NSIAD). | 2018 |
1 |
| 82 |
29478202 | Activation of AQP2 water channels without vasopressin: therapeutic strategies for congenital nephrogenic diabetes insipidus. | 2018 Jun |
1 |
| 83 |
29556787 | Dysregulation of the Renin-Angiotensin System and the Vasopressinergic System Interactions in Cardiovascular Disorders. | 2018 Mar 19 |
5 |
| 84 |
29594432 | Novel and recurrent variants in AVPR2 in 19 families with X-linked congenital nephrogenic diabetes insipidus. | 2018 Sep |
1 |
| 85 |
29664160 | Hyponatremia and activation of vasopressin secretion are both independently associated with 30-day mortality: results of a multicenter, observational study. | 2018 Sep |
1 |
| 86 |
29743334 | Randomised controlled trial of high versus ad libitum water intake in patients with autosomal dominant polycystic kidney disease: rationale and design of the DRINK feasibility trial. | 2018 May 9 |
1 |
| 87 |
29925069 | Vasopressin and Diabetic Kidney Disease. | 2018 |
1 |
| 88 |
29925070 | Osmoregulation in Polycystic Kidney Disease: Relationship with Cystogenesis and Hypertension. | 2018 |
2 |
| 89 |
30221840 | Heat acclimatization blunts copeptin responses to hypertonicity from dehydrating exercise in humans. | 2018 Sep |
1 |
| 90 |
30254813 | Beer Potomania: A View on the Dynamic Process of Developing Hyponatremia. | 2018 Jul 22 |
2 |
| 91 |
30563134 | Water Intake, Water Balance, and the Elusive Daily Water Requirement. | 2018 Dec 5 |
1 |
| 92 |
27852737 | Role of fructose and fructokinase in acute dehydration-induced vasopressin gene expression and secretion in mice. | 2017 Feb 1 |
4 |
| 93 |
27989461 | Bidirectional Anticipation of Future Osmotic Challenges by Vasopressin Neurons. | 2017 Jan 4 |
1 |
| 94 |
28081165 | Urine Concentrating Capacity, Vasopressin and Copeptin in ADPKD and IgA Nephropathy Patients with Renal Impairment. | 2017 |
1 |
| 95 |
28117000 | Vasopressin and Related Peptides; Potential Value in Diagnosis, Prognosis and Treatment of Clinical Disorders. | 2017 |
1 |
| 96 |
28326667 | The V2 receptor antagonist tolvaptan raises cytosolic calcium and prevents AQP2 trafficking and function: an in vitro and in vivo assessment. | 2017 Sep |
1 |
| 97 |
28336531 | Vasopressin-induced serine 269 phosphorylation reduces Sipa1l1 (signal-induced proliferation-associated 1 like 1)-mediated aquaporin-2 endocytosis. | 2017 May 12 |
1 |
| 98 |
28352627 | Treatment of Cirrhosis-Associated Hyponatremia with Midodrine and Octreotide. | 2017 |
1 |
| 99 |
28432473 | Vasopressin and Vasopressin Antagonists in Heart Failure. | 2017 |
1 |
| 100 |
28577072 | Regulation of renal Na-(K)-Cl cotransporters by vasopressin. | 2017 Aug |
1 |